39578527|t|Dual anti-inflammatory activities of COX-2/5-LOX driven by kratom alkaloid extracts in lipopolysaccharide-induced RAW 264.7 cells.
39578527|a|Cyclooxygenase (COX) and lipoxygenase (LOX) enzymes play a pivotal role in producing pro-inflammatory eicosanoids, including prostaglandins (PGs) and leukotrienes (LTs), in the inflammation process. Mitragynine is a primary alkaloid contained in the kratom's leaves and has been reported to show anti-inflammatory activity by suppressing COX-2 mRNA translation to lowering PGs synthesis. In this study, the Kratom's alkaloid extract containing ~ 46% mitragynine was found to exhibit dual inhibition activity towards COX-2/5-LOX enzymes at concentrations below 25 ppm in the LPS-induced RAW 264.7 macrophage cells. At these levels, no cell toxicity was observed while the cells became death (e.g., 10-46% viability at 50-100 ppm) and only COX-2 inhibition activity was observed after exposed with more than 25 ppm of alkaloid extract. In contrast, the methanolic-crude extract of Kratom's leaf containing ~ 5% mitragynine showed no inhibition toward COX-2/5-LOX enzymes and did not toxic onto the cells, even after treated at 100 ppm. The alkaloid extract suppressed several antiinflammation parameters, including ROS (64% reduction at 25 ppm), NO (30% reduction at 25 ppm), TNF-alpha (~ 50% reduction at 25 ppm), and IL-6 production (60% reduction at 6.25 ppm). In silico molecular studies indicated strong binding affinity of Kratom alkaloids to COX-2 and 5-LOX active sites, supporting the Kratom's alkaloids to have great potential dual inhibition activity towards COX-2/5-LOX enzymes and to be developed as a safer NSAIDs with fewer side effects.
39578527	10	22	inflammatory	Disease	MESH:D007249
39578527	59	83	kratom alkaloid extracts	Chemical	-
39578527	87	105	lipopolysaccharide	Chemical	MESH:D008070
39578527	114	123	RAW 264.7	CellLine	CVCL:0493
39578527	220	232	inflammatory	Disease	MESH:D007249
39578527	233	244	eicosanoids	Chemical	MESH:D015777
39578527	256	270	prostaglandins	Chemical	MESH:D011453
39578527	272	275	PGs	Chemical	MESH:D011453
39578527	281	293	leukotrienes	Chemical	MESH:D015289
39578527	295	298	LTs	Chemical	MESH:D015289
39578527	308	320	inflammation	Disease	MESH:D007249
39578527	330	341	Mitragynine	Chemical	MESH:C001801
39578527	355	363	alkaloid	Chemical	MESH:D000470
39578527	381	387	kratom	Species	170351
39578527	432	444	inflammatory	Disease	MESH:D007249
39578527	469	474	COX-2	Gene	17709
39578527	504	507	PGs	Chemical	MESH:D011453
39578527	538	563	Kratom's alkaloid extract	Chemical	-
39578527	581	592	mitragynine	Chemical	MESH:C001801
39578527	705	708	LPS	Chemical	MESH:D008070
39578527	717	726	RAW 264.7	CellLine	CVCL:0493
39578527	770	778	toxicity	Disease	MESH:D064420
39578527	869	874	COX-2	Gene	17709
39578527	947	963	alkaloid extract	Chemical	-
39578527	1040	1051	mitragynine	Chemical	MESH:C001801
39578527	1169	1185	alkaloid extract	Chemical	-
39578527	1244	1247	ROS	Chemical	-
39578527	1275	1277	NO	Chemical	MESH:D009614
39578527	1305	1314	TNF-alpha	Gene	21926
39578527	1348	1352	IL-6	Gene	16193
39578527	1458	1474	Kratom alkaloids	Chemical	MESH:C001801
39578527	1478	1483	COX-2	Gene	17709
39578527	1488	1493	5-LOX	Gene	11689
39578527	1523	1541	Kratom's alkaloids	Chemical	-
39578527	Positive_Correlation	MESH:D011453	MESH:D007249
39578527	Association	MESH:D011453	17709
39578527	Negative_Correlation	MESH:C001801	MESH:D007249
39578527	Negative_Correlation	MESH:C001801	MESH:D011453
39578527	Association	MESH:C001801	11689
39578527	Positive_Correlation	MESH:D015289	MESH:D007249
39578527	Negative_Correlation	MESH:C001801	17709
39578527	Association	MESH:D007249	17709

